Consensus GSK plc Nyse

Equities

GSK

US37733W2044

Real-time Estimate Cboe BZX Other stock markets 03:33:15 2024-04-25 pm EDT			5-day change	1st Jan Change
40.9 ^USD	+0.11%		+4.23%	+10.44%

07:58pm	Sector Update: Health Care Stocks Drop in Afternoon Trading	MT
07:00pm	GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	MT

Evolution of the average Target Price on GSK plc

Price target over the last 5 years

History of analyst recommendation changes

099f5699b316a8b2a850540578d0b0d.HuAQLBuh_-qVX-G4NgpC1gD-Urm_ZWGZVy3olpQR4Ho.dZNjVW_3sKvUFtmJeVoWoGK4MO7gVT7LZ17aosddrUNTs1ZcLdiFm_oJrA~353c6b28967ec62a33300c31005d5c2f

Analyst Recommendations on GSK plc

GSK : Gets a Sell rating from JP Morgan	Apr. 24	ZD
GSK : Gets a Buy rating from Bernstein	Apr. 24	ZD
GSK : Barclays sticks Neutral	Apr. 08	ZD
Barclays Lifts GSK PT, Maintains Equalweight Rating	Apr. 08	MT
Wizz Air raised; HSBC cuts Rentokil to 'hold'	Apr. 08	AN
GSK : Barclays reiterates its Neutral rating	Apr. 04	ZD
GSK : Berenberg gives a Buy rating	Apr. 03	ZD
GSK : Sell rating from JP Morgan	Mar. 28	ZD
GSK : Buy rating from Jefferies	Mar. 20	ZD
GSK : UBS reaffirms its Buy rating	Mar. 19	ZD
UBS Keeps GSK at Buy, Lifts PT	Mar. 19	MT
GSK : UBS raises its target price	Mar. 19	CF
Investec cuts ConvaTec; RBC raises Vistry	Mar. 19	AN
GSK : JP Morgan reaffirms its Sell rating	Mar. 18	ZD
ANALYST RECOMMENDATIONS : Coinbase, Dell Technologies, Mongodb, Broadcom, Lucid Group...	Mar. 08
GSK : Receives a Sell rating from JP Morgan	Mar. 07	ZD
GSK : UBS reaffirms its Buy rating	Mar. 07	ZD
Guggenheim Upgrades GSK to Buy From Neutral	Mar. 04	MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04
GSK : Berenberg reaffirms its Buy rating	Feb. 27	ZD
GSK : Gets a Buy rating from Deutsche Bank	Feb. 21	ZD
Berenberg Lifts GSK PT, Maintains Buy Rating	Feb. 15	MT
Jefferies cuts Kingfisher but Citi raises	Feb. 15	AN
British stocks rise on recession-induced rate cut hopes	Feb. 15
GSK : Berenberg maintains a Buy rating	Feb. 15	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.36 GBP

Average target price

20.06 GBP

Spread / Average Target

+22.60%

High Price Target

34.79 GBP

Spread / Highest target

+112.64%

Low Price Target

12 GBP

Spread / Lowest Target

-26.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GSK plc

JPMORGAN	James Gordon
BERNSTEIN RESEARCH	Justin Smith
Barclays
BERENBERG	Kerry Holford
UBS
JEFFERIES	Peter Welford
Guggenheim
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
Citigroup
Jefferies & Co.
Deutsche Bank Securities
alphavalue	Abhishek Raval
DZ BANK	Elmar Kraus
Morgan Stanley
Berenberg Bank
CREDIT SUISSE	Dominic Lunn
HSBC
GOLDMAN SACHS	Keyur Parekh
Bank of America Securities/Merrill Lynch
Stifel Nicolaus
ODDO BHF
Societe Generale
Liberum Capital
J.P. Morgan Chase
DEUTSCHE BANK	Emmanuel Papadakis
KEPLER CHEUVREUX	David Evans
BAADER BANK
SVB Leerink
LBBW
BANK OF AMERICA (BOFA)	Graham Parry

Ratings for GSK plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar